Advanced Research Projects Agency for Health (ARPA-H), established in 2022, supports transformative high-impact research to drive biomedical and health breakthroughs — ranging from molecular to societal — to provide transformative solutions for all patients.
Modeled after DARPA, this new federal agency represents an important potential funder for the CU Anschutz research community. With a $2.5B budget, this funding agency is expected to speed the development of treatment and cures for diseases, tacking the biggest threats to human health.
For ARPA-H questions, contact Erin Calhoun.
| Program | Proposer’s Day | Abstract/Solution Summary | Full Proposal |
| BioStabilization Systems (BoSS) | January 29, 2026 (registration) Washington D.C./Hybrid | 2/19/2026 | March 26, 2026 (By invite only) |
| Autonomous Interventions and Robotics (AIR) | 12/16/2025 (registration) Bethesda, MD\Hybrid | 1/16/2026 | 3/30/2026 (By invite only) |
| Making Obstetrics Care Smart (MOCS) | 12/11/2025 (registration) Washington, DC/Hybrid | Required Pre-Proposal Discussion with ARPA-H Staff: 12/15/2025-12/19/2025 (Request a session via the Ask a Question form in the ARPA-H Solutions Portal) | 1/21/2026 (By invite only) |
| Evidence-Based Validation & Innovation for Rapid Therapeutics in Behavioral Health (EVIDENT) | 12/10/2025 (registration) Arlington, VA/Hybrid | 12/22/2025 | Rolling (By invite only) |
| Treating Hereditary Rare Diseases with In Vivo Precision Genetic Medicines (THRIVE) | Closed | 12/19/2025 (By invite only) | |
| Genetic Medicines and Individualized Manufacturing for Everyone (GIVE) | 12/19/2025 | 2/27/2026 (By invite only) | |
| Mission Office Innovative Solutions Openings* | NA | Solution Summaries Expiration: March 3, 2029 (rolling submission) | March 3, 2029 |
*General BAA closed on 3/14/2024 and replaced with the Mission Office Innovative Solutions Openings. See details on about the awarded projects to date.